header
Local cover image
Local cover image
Image from OpenLibrary

LAPTM4B : A novel biomarker for hepatocellular carcinoma / Marwa Ahmed Ali Mohammed Ali Elgebeli ; Supervised Olfat Gamil Shaker , Yasser Hussein Nassar , Amr Aly Zahra

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Marwa Ahmed Ali Mohammed Ali Elgebeli , 2014Description: 97 P. ; 25cmOther title:
  • دلاله كيميائيه جديده لسرطان الكبد LAPTM4B [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Medical Biochemistry Summary: Liver cancer is the fifth most common cancer worldwide and the third most deadly. This study aimed to explore the association of LAPTM4B gene polymorphism with HCC in Egyptian patients and whether this genetic polymorphism is associated with the clinicopathological characteristics of the disease. The study included 70 patients with hepatocellular carcinoma. And 50 healthy subjects serving as control. Physical and clinical examinations were done to all subjects. 10 ml of blood were collected from each subject. The following was done; Liver function tests, CBC, DNA extraction from whole blood, genotyping of LAPTM4B gene by PCR, agarose gel electrophoresis and quantitation of protein level of LAPTM4B by ELISA. LAPTM4B *2 / 2 was associated with a significant increased risk of HCC compared with LAPTM4B*1 / 1 (p = 0.006). It is also found that the frequency of allele *2 was higher in HCC (47.9%) than in controls [p < .05]. There was higher level of LAPTM4B protein among HCC patients genotype 2* / 2* (1680.82 ± 654.89) than those have genotype 1* / 2* (1216.25 ± 650.89) and 1*/1* (1144.80 ± 659.98). There was significant Association of LAPTM4B genotypes, protein level in HCC patients and TNM staging
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.03.Ph.D.2014.Ma.L (Browse shelf(Opens below)) Not for loan 01010110064936000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.03.Ph.D.2014.Ma.L (Browse shelf(Opens below)) 64936.CD Not for loan 01020110064936000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Medical Biochemistry

Liver cancer is the fifth most common cancer worldwide and the third most deadly. This study aimed to explore the association of LAPTM4B gene polymorphism with HCC in Egyptian patients and whether this genetic polymorphism is associated with the clinicopathological characteristics of the disease. The study included 70 patients with hepatocellular carcinoma. And 50 healthy subjects serving as control. Physical and clinical examinations were done to all subjects. 10 ml of blood were collected from each subject. The following was done; Liver function tests, CBC, DNA extraction from whole blood, genotyping of LAPTM4B gene by PCR, agarose gel electrophoresis and quantitation of protein level of LAPTM4B by ELISA. LAPTM4B *2 / 2 was associated with a significant increased risk of HCC compared with LAPTM4B*1 / 1 (p = 0.006). It is also found that the frequency of allele *2 was higher in HCC (47.9%) than in controls [p < .05]. There was higher level of LAPTM4B protein among HCC patients genotype 2* / 2* (1680.82 ± 654.89) than those have genotype 1* / 2* (1216.25 ± 650.89) and 1*/1* (1144.80 ± 659.98). There was significant Association of LAPTM4B genotypes, protein level in HCC patients and TNM staging

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image